Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices

被引:103
|
作者
Jutabha, R
Jensen, DM
Martin, P
Savides, T
Han, SH
Gornbein, J
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Hlth Sci Ctr, Dept Med,Div Digest Dis, Los Angeles, CA USA
[2] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[3] Univ Calif San Diego, Med Ctr, Ctr Ulcer Res & Educ, Digest Dis Res Ctr, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Med Ctr, Cedars Sinai Med Ctr, San Diego, CA 92103 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA
关键词
D O I
10.1053/j.gastro.2005.01.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Standard care for prevention of first esophageal variceal hemorrhage is beta-blockade, but this may be ineffective or unsafe. Our purpose was to compare endoscopic banding with propranolol for prevention of first variceal hemorrhage. Methods: In a multicenter, prospective trial, 62 patients with cirrhosis with high-risk esophageal varices were randomized to propranolol (titrated to reducing resting pulse by 25%) or banding (performed monthly until varices were eradicated) and were followed up on the same schedule for a mean duration of 15 months. The primary end point was treatment failure, defined as the development of endoscopically documented variceal hemorrhage or a severe medical complication requiring discontinuation of therapy. Direct costs were estimated from Medicare reimbursements and fixed or variable charges for services up to treatment failure. Results: Background variables of the treatment groups were similar. The trial was stopped early after an interim analysis showed that the failure rate of propranolol was significantly higher than that of banding (6/31 vs. 0/31; difference, 1.9.4%; P =.0098; 95% confidence interval for true difference, 6.4%-37.2%). Significantly more propranolol than banding patients had esophageal variceal hemorrhage (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%), and the cumulative mortality rate was significantly higher in the propranolol than in the banding group (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%). Direct costs of care were not significantly different. Conclusions: For patients with cirrhosis with high-risk esophageal varices and no history of variceal hemorrhage, propranolol-treated patients had significantly higher failure rates of failure, first esophageal varix hemorrhage, and cumulative mortality than banding patients. Direct costs of medical care were not significantly different.
引用
收藏
页码:870 / 881
页数:12
相关论文
共 50 条
  • [21] A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices
    Svoboda, P
    Kantorová, I
    Ochmann, J
    Kozumplík, L
    Marsová, J
    SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 1999, 13 (06): : 580 - 584
  • [22] Efficacy of Carvedilol Plus Variceal Band Ligation Compared to Carvedilol Alone in Primary Prophylaxis of Variceal Bleed in Cirrhosis With High-Risk Varices: A Single Center Randomized Controlled Study
    Kumar, Jata Shankar
    Kar, Premashis
    Rejliwal, Pravin Kumar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S670 - S670
  • [23] Predicting High-Risk Esophageal Varices in Cirrhosis: A Multi-Parameter Splenic CT Study
    Yan, Cheng
    Xia, Chunhua
    Cao, Qiuting
    Zhang, Jingwen
    Gao, Mingzi
    Han, Jing
    Liang, Xiaohong
    Zhang, Mingxin
    Wang, Lin
    Zhao, Liqin
    ACADEMIC RADIOLOGY, 2024, 31 (12) : 4866 - 4874
  • [24] Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial
    Avgerinos, A
    Armonis, A
    Manolakopoulos, S
    Rekoumis, G
    Argirakis, G
    Viazis, N
    Vlachogiannakos, J
    Adamopoulos, A
    Kanaghinis, T
    Raptis, SA
    GASTROINTESTINAL ENDOSCOPY, 2000, 51 (06) : 652 - 658
  • [25] Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: A meta-analysis of randomized controlled trials
    Bai, Ming
    Qi, Xingshun
    Yang, Man
    Han, Guohong
    Fan, Daiming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 442 - 452
  • [26] Randomized trial of propranolol vs. endoscopic variceal ligation (EVL) in the primary prophylaxis of bleeding from high risk varices in cirrhosis: An interim analysis.
    Sarin, SK
    Lamba, GS
    Kumar, M
    Mishra, A
    Murthy, NS
    HEPATOLOGY, 1997, 26 (04) : 928 - 928
  • [27] Non-Invasive Predictor of High-Risk Esophageal Varices: A Baveno VI Validation Study in Clinical Practice
    Wibawa, I. Dewa Nyoman
    Krisnawardani, Cokorde Istri Yuliandari K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1016 - S1016
  • [28] A RANDOMIZED CONTROLLED-STUDY OF LOW-DOSE AND HIGH-DOSE TERLIPRESSIN IN THE CONTROL OF ACUTE ESOPHAGEAL VARICEAL HEMORRHAGE
    CHANG, TT
    LEE, FY
    TSAI, YT
    LAI, KH
    CHAO, Y
    HSIA, HC
    LIN, HC
    WANG, SS
    LEE, SD
    LO, KJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (05) : 481 - 484
  • [29] Transcatheter Pulmonary Artery Banding in High-Risk Neonates: In-Vitro Study Provoked by Initial Clinical Experience
    Kizilski, Shannen B.
    Recco, Dominic P.
    Sperotto, Francesca
    Lang, Nora
    Hammer, Peter E.
    Baird, Christopher W.
    Maschietto, Nicola
    Hoganson, David M.
    CARDIOVASCULAR ENGINEERING AND TECHNOLOGY, 2023, 14 (05) : 640 - 654
  • [30] Transcatheter Pulmonary Artery Banding in High-Risk Neonates: In-Vitro Study Provoked by Initial Clinical Experience
    Shannen B. Kizilski
    Dominic P. Recco
    Francesca Sperotto
    Nora Lang
    Peter E. Hammer
    Christopher W. Baird
    Nicola Maschietto
    David M. Hoganson
    Cardiovascular Engineering and Technology, 2023, 14 : 640 - 654